<SEC-DOCUMENT>0001628280-20-000118-index.html : 20200103
<SEC-HEADER>0001628280-20-000118.hdr.sgml : 20200103
<ACCEPTANCE-DATETIME>20200103171634
ACCESSION NUMBER:		0001628280-20-000118
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200103
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200103
DATE AS OF CHANGE:		20200103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		20506732

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8k-proformaclinigenproduc.htm
<DESCRIPTION>8-K CLINIGEN PRODUCTS
<TEXT>
Document 1 - file: a8k-proformaclinigenproduc.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>clinigenproductsex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: clinigenproductsex991.htm

</DOCUMENT>
</SEC-DOCUMENT>